Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
02 4월 2013 - 6:06AM
Edgar (US Regulatory)
United States
SECURITY AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OFTHE
SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 000-23495
PacificHealth Laboratories, Inc.
(Exact name of registrant as specified in
its charter)
100 Matawan Road, Suite 150, Matawan,
NJ 07747 732-739-2900
(Address, including
zip code, and telephone number,
including area code, of registrant’s
principal executive offices)
Common Stock, par value $0.0025 per share
(Title of each class of securities covered
by this Form)
None
(Title of all other classes of securities
for which
a duty to file reports under section 13(a)
or 15(d) remains)
Please place an X in the box(es) to designate
the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
Rule 12g-4(a)(1)(i)
|
x
|
Rule 12h-3(b)(1)(i)
|
o
|
|
|
Rule 12g-4(a)(1)(ii)
|
o
|
Rule 12h-3(b)(1)(ii)
|
o
|
|
|
Rule 12g-4(a)(2)(i)
|
o
|
Rule 12h-3(b)(2)(i)
|
o
|
|
|
Rule 12g-4(a)(2)(ii)
|
o
|
Rule 12h-3(b)(2)(ii)
|
o
|
|
|
|
|
|
|
Approximate number of holders of record as
of the certification or notice date:
90
Pursuant to the requirements of the Securities
Exchange Act of 1934, PacificHealth Laboratories, Inc.
has caused this certification/notice to be signed on its behalf by the
undersigned duly authorized person.
|
Date:
|
April 1, 2013
|
|
By:
|
/s/ Frederick Duffner
|
|
|
|
|
|
|
Frederick Duffner, President and
|
|
|
|
|
|
|
Chief Executive Officer
|
|
Instruction: This form is required by Rules
12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file
with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant,
by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed
under the signature.
PacificHealth Laboratories (CE) (USOTC:PHLI)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
PacificHealth Laboratories (CE) (USOTC:PHLI)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
